Acamprosate formulations, methods of using the same, and combinations comprising the same

US9427420B2 · kind B2 · utility

Assignee

• Synchroneuron Inc. · US

Inventors

• Barry S. Fogel · Newton, US
• William D. Kerns · Duxbury, US
• Kei-Lai Fong · Berkeley, US
• San-Laung Chow · Penfield, US
• Edward Lin · Sydney, AU
• David Wong · Taoyuan, TW

Key dates

• Filing date: Jun 5, 2014
• Grant date: Aug 30, 2016
• Expiry date: Jun 5, 2034

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K47/38
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.